Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:538401's Return-on-Tangible-Asset is ranked better than 87.1% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.89
vs BOM:538401: 12.66
Maestros Electronics & Telecommunications Systems (BOM:538401) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Maestros Electronics & Telecommunications Systems Return-on-Tangible-Asset Related Terms
Maestros Electronics & Telecommunications Systems Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maestros Electronics & Telecommunications Systems Return-on-Tangible-Asset Chart
Maestros Electronics & Telecommunications Systems Annual Data
BOM:538401 vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Maestros Electronics & Telecommunications Systems's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maestros Electronics & Telecommunications Systems Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 10.48% mean?
Maestros Electronics & Telecommunications Systems (BOM:538401) has a Return-on-Tangible-Asset of 10.48% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Maestros Electronics & Telecommunications Systems and its competitors. This is 121% above median its historical median of 4.74. According to the industry distribution chart, Maestros Electronics & Telecommunications Systems ranks #110 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 12.9%.
Is Maestros Electronics & Telecommunications Systems' Return-on-Tangible-Asset too high?
Maestros Electronics & Telecommunications Systems' current Return-on-Tangible-Asset of 10.48% is 121% above median its 10-year median of 4.74. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.89. Maestros Electronics & Telecommunications Systems' value of 10.48% is 1077.5% above this industry median. Based on the distribution chart, Maestros Electronics & Telecommunications Systems ranks #110 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Maestros Electronics & Telecommunications Systems has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Maestros Electronics & Telecommunications Systems' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Maestros Electronics & Telecommunications Systems ranks #110 out of 853 companies for Return-on-Tangible-Asset. This places Maestros Electronics & Telecommunications Systems in the top 13% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.89. Maestros Electronics & Telecommunications Systems' value of 10.48% is 1077.5% above this benchmark. While the company's 10-year median is 4.74 vs. the industry median of 0.89, Maestros Electronics & Telecommunications Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maestros Electronics & Telecommunications Systems's current Return-on-Tangible-Asset of 10.48% is 1077.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Maestros Electronics & Telecommunications Systems and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maestros Electronics & Telecommunications Systems's current Return-on-Tangible-Asset is 10.48%, which is 121% above median its own 10-year median of 4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maestros Electronics & Telecommunications Systems stock overvalued right now?
Based on GuruFocus' analysis, Maestros Electronics & Telecommunications Systems (BOM:538401) is currently considered Fairly Valued. The stock's GF Value™ is ₹171.40, compared to a current price of ₹157.00 — trading 8.4% below its estimated fair value. The current Return-on-Tangible-Asset is 10.48%, which is 121% above median its 10-year median of 4.74 and 1077.5% above the Medical Devices & Instruments industry median of 0.89. Maestros Electronics & Telecommunications Systems' overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Maestros Electronics & Telecommunications Systems (BOM:538401), the current Return-on-Tangible-Asset is 10.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maestros Electronics & Telecommunications Systems (BOM:538401) Overvalued in 2026?
Based on GuruFocus' analysis, Maestros Electronics & Telecommunications Systems stock appears to be undervalued.
The current stock price of ₹157.00 is trading 8.4% below its estimated GF Value™ of ₹171.40.
GuruFocus considers Maestros Electronics & Telecommunications Systems to be Fairly Valued.
Key valuation signals for BOM:538401:
Return-on-Tangible-Asset: 10.48% (121% above median its 10-year median of 4.74)
GF Value™: ₹171.40 vs. price of ₹157.00 (8.4% below fair value)
Industry Position: 1077.5% above the Medical Devices & Instruments median (#110 of 853)
No single metric tells the full story. See the BOM:538401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maestros Electronics & Telecommunications Systems Ltd is engaged in the business of manufacturing medical equipment and telemedicine. The company operates through three main segments of business: Medical, Electronics & Instrumentation, and Telemedicine. The company generates the majority of its revenue from the Medical segment. It is a medical diagnostic equipment organisation, dedicated to empowering medical professionals and institutions treating cardiac, gynaecology, and critical care patients nationwide. The group offers a portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems, and others.
68GF Score
Get the complete analysis for BOM:538401
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538401 has been successfully added to your 
